Ledger.Open graph →
SEC Form D · filed February 12, 2014

Nuron Biotech, Inc

Offering
$35.7M
Sold
$22.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EXTON, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Todd D. Davis · Exton, PADirectorGregory D. Brown · Exton, PADirectorMatthew Q. Reber · Exton, PADirectorVithalbhai D. Dhaduk · Exton, PADirectorMukeshbhai D. Patel · Exton, PADirectorWarren D. Cooper · Exton, PAExec · DirectorShankar Musunuri · Exton, PADirectorAndrew L. Romberger, Esq · Exton, PAExecDavid D. Zeng, Ph.D · Exton, PADirectorWendy D. Dicocco, Cpa · Exton, PAExecDavid Van Meter · Irvine, CADirectorRoberto Silvotti · LONDON, United KingdomDirectorThong Yuen Poon · Irvine, CADirectorDouglas Roeder · Irvine, CADirectorMark D. Finn · San Diego, CADirectorChristopher P. Richards · San Diego, CADirectorEugene D. Linden · San Diego, CAExecRene Mouchotte · LONDON, United KingdomDirectorWendy D. Dicocco, Cpa · Exton, PAExecWarren D. Cooper · Exton, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗